A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea

NACompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Rosacea
Interventions
OTHER

Anatabloc Cream

subject will apply active cream topically, twice per day according to instructions

OTHER

Placebo Cream

subject will apply placebo cream topically, twice per day according to instructions

Trial Locations (3)

10022

Diane Berson, MD, New York

34209

Susan H. Weinkle, MD, Bradenton

70124

Lupo Center for Aesthetic & General Dermatology, New Orleans

All Listed Sponsors
lead

Rock Creek Pharmaceuticals, Inc.

INDUSTRY

NCT01740934 - A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea | Biotech Hunter | Biotech Hunter